Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 24594478)

Published in Neuropharmacology on March 01, 2014

Authors

Peter H Hutson1, Michael Pennick2, Roger Secker2

Author Affiliations

1: Shire Pharmaceuticals, Chesterbrook, PA, USA. Electronic address: phutson@shire.com.
2: Shire Pharmaceuticals, Basingstoke, UK.